Jiaming Yu Selected Research

Syphilis

11/2022

A Cost-effectiveness Analysis of a Mobile Phone-Based Integrated HIV-Prevention Intervention Among Men Who Have Sex With Men in China: Economic Evaluation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiaming Yu Research Topics

Disease

5	Neoplasms (Cancer) 01/2023 - 01/2019
2	Bacterial Infections (Bacterial Infection) 10/2023 - 05/2023
2	Wounds and Injuries (Trauma) 10/2023 - 05/2023
2	Osteosarcoma (Osteogenic Sarcoma) 01/2023 - 10/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 12/2018
1	Hypochromic Anemia (Chlorosis) 04/2024
1	Frailty 01/2023
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 11/2022
1	HIV Infections (HIV Infection) 11/2022
1	Syphilis 11/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2022
1	Sarcopenia 01/2022
1	Dysbiosis 12/2021
1	Neoplasm Metastasis (Metastasis) 10/2021
1	Adenocarcinoma 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Lymphatic Metastasis 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Cataract (Cataracts) 07/2019
1	Degenerative Myopia 03/2019
1	Infections 01/2019
1	Multiple Myeloma 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Esophageal Squamous Cell Carcinoma 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Synovial Sarcoma (Synovioma) 01/2019
1	Testicular Neoplasms (Testicular Cancer) 12/2018
1	Fever (Fevers) 12/2018
1	Adenocarcinoma of Lung 12/2018
1	Lung Neoplasms (Lung Cancer) 12/2018
1	Anemia 12/2018

Drug/Important Bio-Agent (IBA)

2	ChitosanIBA 10/2023 - 05/2023
2	Deep Eutectic SolventsIBA 10/2023 - 05/2023
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2021
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019 - 12/2018
1	Proline (L-Proline)FDA Link 04/2024
1	Polyvinyl AlcoholIBA 10/2023
1	Biocompatible Materials (Biomaterials)IBA 05/2023
1	SolventsIBA 05/2023
1	AntiportersIBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	AntioxidantsIBA 01/2023
1	Galectin 3 (LGALS3)IBA 01/2023
1	Cysteine (L-Cysteine)FDA Link 01/2023
1	Cystine (L-Cystine)IBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	FicollIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2023
1	Glutamic Acid (Glutamate)FDA Link 01/2023
1	Bile Acids and Salts (Bile Acids)IBA 12/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	LipidsIBA 01/2021
1	NucleotidesIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	EstersIBA 10/2020
1	Tyrosine Kinase InhibitorsIBA 10/2020
1	Nanoparticle Drug Delivery SystemIBA 10/2020
1	AmidesIBA 10/2020
1	apatinibIBA 10/2020
1	Retinaldehyde (Retinal)IBA 03/2019
1	Pattern Recognition ReceptorsIBA 01/2019
1	InterferonsIBA 01/2019
1	AntigensIBA 12/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2018

Therapy/Procedure

5	Therapeutics 01/2022 - 12/2018
1	Biological Dressings 10/2023
1	Condoms (Condom) 11/2022
1	Drug Therapy (Chemotherapy) 10/2021
1	Phacoemulsification 07/2019
1	Immunotherapy 01/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2018